Patents by Inventor Aaron D. EDWARDS

Aaron D. EDWARDS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATMENT OF LIQUID CANCERS
    Publication number: 20230021636
    Abstract: As described below, the present invention features genetically modified immune cells having enhanced anti-neoplasia activity, resistance to immune suppression, and decreased risk of eliciting a graft versus host reaction, or a combination thereof. The present invention also features methods for producing and using these modified immune effector cells.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 26, 2023
    Applicants: Beam Therapeutics Inc., UCL BUSINESS LTD.
    Inventors: Jason Michael GEHRKE, Aaron D. EDWARDS, Ryan MURRAY, Waseem QASIM
  • MODIFIED IMMUNE CELLS HAVING ENHANCED ANTI-NEOPLASIA ACTIVITY AND IMMUNOSUPPRESSION RESISTANCE
    Publication number: 20220133790
    Abstract: As described below, the present invention features genetically modified immune cells having enhanced anti-neoplasia activity, resistance to immune suppression, and decreased risk of eliciting a graft versus host reaction, or a combination thereof. The present invention also features methods for producing and using these modified immune effector cells.
    Type: Application
    Filed: January 16, 2020
    Publication date: May 5, 2022
    Applicant: BEAM THERAPEUTICS INC.
    Inventors: Jason Michael GEHRKE, Aaron D. EDWARDS, Ryan MURRAY